Nightingale Well being Plc
Press launch
27 January 2025 at 9:00 a.m. (EET)
Nightingale Well being Plc (“Nightingale Well being”), a pioneer in illness danger detection and preventative well being, and Enigma Genomics (“Enigma”) have signed a pilot settlement and a letter of intent to offer the Nightingale Distant Well being Examine to Enigma’s prospects within the Kingdom of Saudi Arabia and the MENA area.
Enigma, an revolutionary AI-powered genomics platform, is aiming to rework healthcare with superior genetic evaluation for diagnostic and analysis functions. Offering direct-to-consumer and medical genetic sequencing, Enigma empowers people and medical professionals to make knowledgeable selections targeted on illness prevention and well being optimization. Aiming to guide precision drugs in Saudi Arabia and the Center East, Enigma is increasing its take a look at choices by using the newest applied sciences to reinforce preventative healthcare, which has enabled Enigma to launch the area’s first large-scale complete genome sequencing-based genetic screening program, enabling people to make knowledgeable healthcare selections for higher well being and well-being.
The letter of intent accommodates 4 phases for the collaboration: pilot, service launch, enlargement of gross sales and full-scale industrial adoption. The businesses will begin preparations for the pilot in early 2025 and the purpose is to transition section by section to a continued industrial service mannequin making the Nightingale Distant Well being Examine broadly accessible for Enigma’s prospects. The Nightingale Distant Well being Examine supplies illness danger evaluation for a number of continual ailments utilising only a single blood pattern with out the necessity to accumulate medical parameters similar to BMI, household historical past or blood stress. As well as, Nightingale Distant Well being Examine precisely measures dozens of biomarkers from a single blood pattern collected at-home, together with cholesterols, apolipoproteins and fatty acids like omega-3. Many of those blood biomarkers have established medical relationships to illness and may help information essential life-style interventions – similar to weight loss plan and train.
“We share the imaginative and prescient of serving to people and well being techniques to determine well being dangers and forestall ailments, and mixing our illness danger evaluation to Enigma’s genetics merchandise supplies extra complete well being evaluation and insights into what sort of preventative actions are most impactful” says Teemu Suna, CEO and Founding father of Nightingale Well being. “We’re excited concerning the alternative to carry Nightingale Well being’s expertise into a brand new area, the place we strongly consider we will contribute to constructing the preventative well being system” he continues.
“At Enigma Genomics, we’re pushed by a imaginative and prescient to rework healthcare via innovation and customized options. Partnering with Nightingale Well being is an thrilling step ahead on this journey. By integrating their cutting-edge Distant Well being Examine into our choices, we’re giving people throughout the MENA area the instruments to know their well being dangers and take proactive steps towards prevention. This collaboration is extra than simply expertise—it’s about empowering individuals to guide more healthy, extra knowledgeable lives,” stated Eng. Musaad AlDubayan, Managing Director of Enigma Genomics.
For additional info, please contact:
Teemu Suna, CEO
ir@nightingalehealth.com
About Nightingale Well being
Nightingale Well being’s mission is to construct sustainable healthcare and cut back well being inequalities. Nightingale Well being has developed the world’s most superior well being verify that gives danger detection for a number of continual ailments from a single blood pattern. Nightingale’s Well being Examine may be scaled to complete populations at a low price, and it may change most of the present medical danger assessments. Detecting illness dangers on a inhabitants degree permits for the efficient focusing on and monitoring of well being interventions, and higher prevention of the onset of continual ailments. With each pattern we assist to create a more healthy world.
Nightingale Well being operates globally with a dad or mum firm in Finland and 7 subsidiaries in nations similar to Japan, the US, Singapore, and the UK. Nightingale Well being has prospects in additional than 34 nations within the healthcare and medical analysis sectors. The corporate’s expertise is being utilized in most of the world’s main well being initiatives, such because the UK Biobank, and over 600 peer-reviewed publications validate the expertise. The corporate’s Sequence B shares are listed on the First North Progress Market Finland market. Learn extra: https://nightingalehealth.com/
About Enigma Genomics
Enigma Genomics is an built-in molecular, medical, and computational genomics platform devoted to decoding the complexities of the human genome to ship actionable insights for sufferers, researchers, and healthcare suppliers. By combining state-of-the-art sequencing applied sciences with revolutionary AI-driven techniques, Enigma Genomics is revolutionizing the best way we perceive, interpret, and apply genetic info. The corporate’s mission is to empower people and medical professionals with exact, customized genomic knowledge, enabling knowledgeable selections that rework well being and life outcomes whereas accelerating the event of focused therapies. Leveraging these advances, Enigma Genomics has designed and executed state-of-the-art packages for presidency and personal healthcare techniques, driving innovation and enhancing well being outcomes on a bigger scale.
For inquiries:
Data@enigmagenomics.com
https://enigmagenomics.com/web/
Tags:
